# Ascorbic Acid Treatment in Congenital Glucocorticoids and Mineralocorticoids Deficiency Due to NNT Mutation

> **NCT02838472** · NA · UNKNOWN · sponsor: **Hadassah Medical Organization** · enrollment: 3 (estimated)

## Conditions studied

- Glucocorticoids Deficiency

## Interventions

- **DRUG:** Ascorbic Acid

## Key facts

- **NCT ID:** NCT02838472
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2017-08
- **Final completion:** 2017-12
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2016-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02838472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02838472, "Ascorbic Acid Treatment in Congenital Glucocorticoids and Mineralocorticoids Deficiency Due to NNT Mutation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02838472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*